By Dr. Junda Woo, Medical Director and Local Health Authority, San Antonio Metropolitan Health District
Sandra Zaragoza, Senior Marketing and Communications Specialist, Health Confianza
San Antonio, TEXAS — As respiratory virus season approaches, health professionals and community health workers will be working in a shifting vaccine landscape. While guidance and rules may change, the collective goal stays the same – providing access to vaccines and scientifically accurate, evidence-based guidance to support people’s health decisions.
To help navigate this challenging time, here are some insights and resources.
Who is Eligible for COVID vaccines?
The U.S. Centers for Disease Prevention & Control (CDC), U.S. Food and Drug Administration leaders and medical societies all agree that an annual COVID vaccination is recommended for people at risk for severe illness and people ages 65 and older.
Where they differ is in recommendations for COVID shots for the following populations: healthy adults under 65, pregnant people and healthy children. Part of the reason is that we collectively have more immunity, from infections and vaccinations, than we did in years past.
We are still waiting for 2025-26 CDC recommendations. For 2024-25 (as of September), see the box below.
| Annual COVID Vaccine Recommendations (As of Sept. 2025) | |||
| Group | CDC 2024-25 Immunization Schedule | FDA leaders (New England Journal of Medicine article) | Medical Societies |
| Healthy adults under 65 | Yes | No | Same as CDC |
| Pregnancy | “No guidance/
Not Applicable” |
Yes | Yes (ACOG) |
| Healthy children | Shared decision-making | Research needed | Yes, especially for ages 6 mos.-2 years (AAP) |
Because the differences in guidance may be confusing, think about encouraging your patients and clients to engage in shared decision-making with their health care providers. Shared decision-making is where patients and clinicians collaborate to make healthcare decisions, considering both medical evidence and the patient’s own values and preferences. An example of shared decision-making is when parents choose to vaccinate their child after discussing it with their healthcare provider.
Less Convenient, More Expensive
Unfortunately, as of Oct. 1, Texas’ Adult Safety Net program will stop covering COVID vaccines for people who are uninsured. We are awaiting news about the Vaccines for Children program coverage.
Insurers seem likely to cover COVID vaccines for everyone until Jan. 1, 2026, when the new benefit year begins.
Access to vaccines at pharmacies will vary by state (map). Fortunately, Texas pharmacists will give the vaccine. For people who pay out of their own pockets, discount coupons can lower the cost.
For people at risk for severe illness who cannot access the vaccine, the old standbys still work: clean air, handwashing, staying away from others who are sick, masking, getting tested.
Counseling and Consents Are Changing
In June, the FDA expanded the myocarditis warning on mRNA vaccines. mRNA vaccines have been linked, rarely, to myocarditis and pericarditis—inflammation of the heart muscle and tissue.
The reaction is most common in males ages 12 to 24, occurring in 27 of every 1 million doses. To lower this risk, the CDC suggests spacing out 1st and 2nd doses by 8 weeks in young men. Importantly, COVID infection and disease also can cause heart conditions.
When obtaining a COVID vaccine, patients may be asked to sign a new informed consent form that was required by the Texas Legislature (HB 4535).
Vaccines for Children
The American Academy of Pediatrics (AAP) published its own evidence-based immunization schedule for children in August. The schedule offers recommendations on RSV, flu and COVID, as well as other key vaccines.
What’s New with Flu Vaccines?
Metro Health continues to promote the importance of flu vaccines in reducing severe illness and hospitalization, especially in people who are immunocompromised, children and elders. Last season, 275 U.S. children died from the flu, and 90% were not fully vaccinated.
Starting this fall, multidose vials of flu vaccine no longer will contain thimerosal. Thimerosal is an FDA-approved antifungal/antibacterial that was only in multidose flu vials (4% to 7% of flu vaccines). It is not in any routine childhood vaccines.
You may see ads this fall for a self-administered, at-home nasal spray vaccine. Unlike flu shots, the nasal spray uses a form of the live virus (weakened) and so is not recommended for pregnant or immunosuppressed people, among others. It is approved for ages 2 through 49 and could be a good option for people with needle phobia.
How is Metro Health Navigating the Conflicting Guidance?
As vaccine expertise and advice change on a federal level, old-school science-based recommendations will continue through medical specialty societies and new coalitions. Metro Health will monitor the evolving landscape and share credible information with our community as we receive it. Subscribe to Metro Health’s clinician newsletter here.













